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 Abstract 
In peripheral blood there are very rare circulating stem/progenitor cells (CSPCs) with primitive characters and the capacity to 
differentiate into cardiovascular and other lineages. These cells are promising biomarkers of the organism‟s resilience and of  its ability 
to repair injuries. However, because of its complexity, the system of CSPCs has not yet been described by traditional methods in a 
coherent and simple enough manner to be clinically useful. In response to this limitation, we proposed the CSPC system could be 
directly assessed by gene expression analysis of peripheral blood mononuclear cells (PBMCs). Initially, 45 genes representing the 
most used markers of primitivity and differentiation were tested. Among these, 15 genes were organized as a module of the blood 
transcriptional network which inversely depended on age, blood pressure, and vascular stiffness of donors, as expected from CSPCs. 
To identify more members of this module, we analyzed 503 Affymetrix microarrays from public databases hybridized with RNA of 
normal human PBMCs from children (where the primitive genes were better expressed), adults, and burn victims (a response to an 
injury condition that is preferable to actual cardiovascular patients because of the lack of other risk factors which complicate the 
interpretation). Normalized data was analyzed by the bioinformatics co-variation method known as “guilt-by-association”. This 
approach identified 107 potential candidates from data collected from microarrays on healthy children, many having known roles 
associated with stemness, differentiation, angiogenesis, and/or cardiovascular diseases or repair. A larger study on adults was 
conducted, as well as studies involving burn injury (that induces massive mobilization of CSPCs) and pregnant women suffering from 
preeclampsia (a condition due to deficiencies in CSPCs), for comparison. In conclusion, we show how to expand a new, collective, 
systemic biomarker for the elusive CSPCs that could be used to track their response to injury and to identify patients at risk for 
developing, or already experiencing, cardiovascular diseases. 
 
Figure 1. Defining a core network module with cardiovascular function 
(‘cardiovascular repairome’, CVR) by PCR analysis (Moldovan et al., PlosONE, in 
press). A. Panel of primitive (left column) and differentiation (right column) tested genes. 
B. Example of covariation of primitive and cardiovascular genes in PBMCs from 27 
healthy human subjects. C. Covariation expression matrix of genes in PBMCs from 
normal subjects. A module composed of 15 genes  called CVR (encircled) were found to 
inversely relate to blood donor‟s age, vascular stiffness and central blood pressure 
parameters, suggestive of a vascular protective role similar to CSPCs.  The goal of the 
current project is to expand this network using the Guilt-by-Association (GBA) principle.  
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Table 1: Poor sensitivity of microarrays for detecting genes with low transcripts. 
Affymetrix microarrays from listed GSE studies were analyzed. The table contains 
„presence scores‟ on Affymetrix GeneChips® of the selected gene panel (see Fig. 1). 
Highlighted (yellow) are members of the CVR module. Stars (**) represent genes whose 
presence levels were higher in children than adults. Most of the CVR genes were not 
present in a study where CD34+ cells were pre-selected (of note, even CD34 had an 
incomplete representation). Also indicated are MKI67 and OLR1, two genes with 
increased presence in samples from burn injury.  
Table 2.   Genes with the largest fold change in burn and preeclampsia patients, as compared to prevalence in children 
vs. adults. Orange = Prevalent in burn victims, preeclampsia, and present in the children‟s network; Yellow = Prevalent in burn 
victims and preeclampsia, but not present in children; Red = Prevalent in burn victims and present in the children‟s network, but not 
prevalent in preeclampsia. 
Figure 3:  Covariation-based network structure of an extended panel of primitive and differentiation genes occurring in PBMCs in response to 
burn injury (extended gene panel compiled by NIH‟s Stem Cells Interest Group). Network detection of genes with a Presence Score > 0.5 via Clique Mining 
was performed on over 300 suggested stem and progenitor cell related genes.  Networks were created for controls (A), early burn victims (1-10 days) (B), 
and late burn victims (11-49 days) (C).  A. No modules were common between the controls and burn victims as is established by the different colored 
modules.  B-C. However, similar modules did arise between the early and late burn victims.  Two modules had a majority of their members present in both 
groups (blue and yellow) while the red and green modules had more limited similarities between groups. 
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Seed 
Gene 
ID Gene Symbol Gene Name R Functional Relevance 
NOS3 
 221790_s_at LDLRAP1 Low density lipoprotein receptor adaptor protein 1 0.798 Linked to hypercholesterolemia through mutations which prevent interaction with the LDL receptor 
 209368_at EPHX2 Epoxide hydrolase 2, cytoplasmic 0.780 Regulates vascular tone, nociception, angiogenesis and inflammation. Central role in cardiac hypertrophy, diabetes, hypertension, and pain 
 210349_at CAMK4 Calcium/calmodulin-dependent protein kinase IV 0.765 Indicated in hypertension and regulation of vascular tone.  Plays a pivotal role in BP regulation through the control of endothelial nitric oxide synthase activity 
NANOG 
 232466_at CUL4A Cullin 4A 0.757 Required for hematopoietic stem-cell engraftment and self-renewal 
 1568943_at INPP5D Inositol polyphosphate-5-phosphatase, 145kDa 0.753 Expression is restricted to hematopoietic cells.  The protein functions as a negative regulator of myeliod cell proliferation and survival 
 1559902_at MKL1 Megakaryoblastic leukemia (translocation) 1 0.704 Regulates myofibroblast activation and fibrosis in response to the renin-angiotensin system and post-MI remodeling 
NOTCH4 
 214909_s_at DDAH2 Dimethylarginine / Dimethylaminohydrolase 2 0.737 Expression promotes angiogenesis via regulating VEGF-dependent pathway. Also plays a role in NO generation through methylarginine regulation 
 226564_at ZFAT1 ZFAT zinc finger 1 0.727 Essential for endothelial cell assembly, and may play a critical role in the capillary-like network formation that is involved in vascular remodeling 
 203241_at UVRAG UV radiation resistance associated gene 0.725 Epithelial organizer which directly impinges on epidermal-mesenchymal transition, stemness, senescence, cell death, and cell cycle arrest 
Figure 4: Network reconstruction from the covariation ‘neighborhoods’ of CVR seed genes. Network creation and module detection was done by 
performing regression analysis followed by a Clique Mining visualization on Affymetrix GeneChips® based on RNA isolated from PBMCs of healthy 
children (A), healthy adults (B), and burn victims (C). „Seed‟ genes were required to have a presence score of at least 50%. (A) The red module consists of 
the seed gene OLR1 and its most highly correlated „neighbors‟. Additional seed genes, NOTCH4 (bottom), NANOG (left), and NOS3 (top), are also 
represented along with their most highly correlated neighbors (Pearson correlation > 0.7).  Genes on the gradient of purple to blue are highly 
interconnected with one another as established by the large density of edges between them.  OLR1‟s neighborhood has no connections with the others at 
this edge threshold (w = 0.6).   (B) Colors corresponding to NOTCH4‟s and OLR1‟s neighborhoods were kept consistent as NOTCH4 and OLR1 were the 
only seed genes used in the adult analysis (Presence Score > 0.5).  While most of NOTCH4‟s members are vastly dissimilar from the Children‟s Network, 
many of OLR1‟s neighbors remained some of the most highly correlated genes in the adult study.  Edge strength was lowered (w = 0.4) to show the 
consistent limited connections between the two modules. (C). Genes exhibiting the largest fold change in expression value from controls to early and late 
term burn victims were recorded.  These were compared to genes which had high fold change in expression level from the preeclampsia study.  Genes 
with large fold changes ( >1 on log scale) in both studies, as well as genes with large fold changes that were represented in OLR1‟s network in children, 
were kept for analysis.  Module representation shows much higher overall connectivity and strength in connectivity in OLR1‟s module, though OLR1 is 
slightly less connected.  
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4317 207329_at MMP8   Plays an important role in plaque angiogenesis 2.63 3.32 0.68 - - 1.99 0.037 
4057 202018_s_at LTF   Highly expressed in non-healing wound exudates 2.36 3.09 0.73 - - 2.03 0.001 
3934 212531_at LCN2   An independent renal predictor of incidence of AKI after surgical abdominal aortic aneurysm (AAA) repair 2.30 3.20 0.89 1.58 0.098 1.85 0.001 
10562 212768_s_at OLFM4   Marker of intestinal stem cells 1.96 2.39 0.43 - - 1.88 0.077 
10321 207802_at CRISP3   Specific neutrophil granules protein, secreted as an extracellular matrix component 1.51 1.12 -0.39 - - 1.83 0.052 
671 205557_at BPI   Antibacterial activity against Gram-negative bacteria 1.43 2.43 1.00 2 0.021 2.01 0.005 
1669 207269_at DEFA4   Neutrophil protein with antimicrobial activity against Gram-negative bacteria 0.55 2.66 2.11 2.36 0.011 2.49 0.001 
4680 211657_at CEACAM6   Implicated in cell adhesion, cellular invasiveness, angiogenesis, and inflammation 0.45 2.42 1.96 2.1 0.041 1.99 0.023 
6037 206851_at RNASE3   Eosinophil major basic protein with pro-angiogenic effects 0.54 1.42 0.89 - - 1.89 0.027 
154664 1553605_a_at ABCA13   Markers of hMSC 0.18 1.16 0.98 1.56 0.086 - - 
820 210244_at CAMP   Induces angiogenesis via PGE2-EP3 signaling in endothelial cells 0.59 1.06 0.47 - - 1.66 0.002 
4318 203936_s_at MMP9   
Involved in mobilization of hematopoietic progenitor cells from bone marrow as well as embryonic development, 
reproduction, and tissue remodeling through ECM degradation 
2.56 2.56 -0.01 1.62 0.039 - - 
8993 207384_at PGLYRP1   
Binds to peptidoglycan of bacteria involved in human atherosclerotic lesions.  Increasing levels associated with 
coronary artery calcification and aortic wall thickness 
1.69 2.12 0.43 1.59 0.007 - - 
762 206209_s_at CA4   
Encodes an isozyme expressed on luminal surfaces of pulmonary and other capillaries and proximal renal tubules.  
Related to Ocular Hypotension 
1.54 1.37 -0.17 1.52 0.040 - - 
660 206464_at BMX   
Plays a critical role in TNF-induced angiogenesis, and implicated in the signaling of TEK and FLT1 receptors, 2 
important receptor families essential for angiogenesis 
1.54 1.61 0.07 1.5 0.033 - - 
56729 220570_at RETN   
Resistin levels correlate with oxidative stress and myocardial injury in cardiac surgery patients. It may serve as a 
useful biomarker for ischemia-reperfusion injury 
1.53 1.63 0.09 - - 1.53 0.060 
6947 205513_at TCN1   
Influences human vitamin B-12 levels which have shown to be implicated in congenital heart disease via the folate 
metabolism pathway 
1.47 2.29 0.82 1.75 0.012 1.68 0.008 
1088 206676_at CEACAM8   
Leukocyte activation marker.  Increased leukocyte activation is correlated with coronary artery disease, plaque 
destabilization, and vascular cell dysfunction 
1.18 2.86 1.68 1.9 0.051 2.09 0.004 
1232 208304_at CCR3   
CCR3-dependent chemokine interactions regulate endogenous migration of CD34+ progenitors from bone marrow 
to ischemic but not to normal myocardium 
-1.01 -0.90 0.10 1.84 0.000 1.64 0.001 
260429 1552348_at PRSS33   Serine, protease predominantly expressed in macrophages -1.02 -0.47 0.55 - - 1.73 0.087 
100133941 216379_x_at CD24   
Interacts with P-selectin which mediates rapid rolling of leukocytes over vascular surfaces during the initial steps in 
inflammation 
0.70 1.90 1.19 1.63 0.039 1.52 0.033 
932 210254_at MS4A3   Hematopoietic stem cell cycle regulator -0.05 1.79 1.84 1.83 0.096 1.63 0.085 
5806 206157_at PTX3   
Modulates inflammatory processes, angiogenesis, atherosclerotic lesion development, and ECM formation. 
Released by vascular wall cells as an inflammatory marker 
0.44 1.18 0.74 1.57 0.045 1.69 0.002 
383 206177_s_at ARG1   Reduces nitric oxide production and impairs endothelial function 2.68 2.74 0.05 - - - - 
306 209369_at ANXA3   Potential angiogenic mediator 2.21 2.31 0.10 - - - - 
5004/5005 205041_s_at ORM1/2   Acute phase reactant and bimodal regulator of angiogenesis 1.00 1.06 0.06 - - - - 
4353 203949_at MPO   
Leukocyte activation marker.  Increased leukocyte activation is correlated with coronary artery disease, plaque 
destabilization, and vascular cell dysfunction 
0.39 1.61 1.22 - - - - 
5004 205040_at ORM1   Acute phase reactant and bimodal regulator of angiogenesis 0.98 1.16 0.18 - - - - 
1116 209395_at CHI3L1   Expressed by macrophages, chondrocytes, and vascular SMC; it is a potent angiogenic factor -0.97 0.03 1.00 - - - - 
 Results 
Figure 2. WGCNA attempt to identify additional CVR candidate genes. Scale-Free Topology Graph, Mean Connectivity, and 
Cluster analysis of genes co-varying with at least three CVR members performed by Weighted Gene Covariation Network Analysis 
(WGCNA, Langfelder P, Horvath S.BMC Bioinform. 2008;9:559).  This was done using 8,000 of the most variable genes, a listing of 
over 300 stem and progenitor cell related genes suggested by the NIH, as well as 2,755 genes gathered from the GBA method 
which were correlated (R > 0.4) with at least 3 of the 5 present CVR genes (Presence > 0.5).  Left side represents typical results of 
WGCNA method while the right side represents results from our GBA analysis using WGCNA.  Note that higher beta values lead to 
a loss of information as the Pearson correlations approach zero.  Higher mean connectivity values as well as higher beta values 
required to reach Scale Free Topology would not allow for this analysis to be used for stemness-related genes in peripheral blood. 
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Conclusions  
1. In this proof of concept study, we demonstrate how a ‘guilt-by-association’ principle-based bottom-up approach can be 
applied to reconstruct the transcriptional network, and thus to obtain new candidate genes as members of a pre-existing 
gene module containing rare primitive and differentiation markers, in spite of the low sensitivity of microarrays for mRNA 
detection. 
2. Using this new method, we found a cluster of genes rich in primitive markers, expressed in PBMCs as co-variants of OLR1 
(oxidized LDL receptor, LOX-1), that recurrently occurs on Affymetrix microarrays from normal children and adults, or in 
response to burn injury, and also being among the most modified genes in women with preeclampsia. 
3. At the same time, the coordinate reduction - or going undetectable - of other gene clusters during physiological or 
pathological perturbations illustrate the complex response to injury and repair of the transcriptional landscape in peripheral 
blood, with contribution from the  release into the circulation and recruitment of progenitor cells, and from modulation of 
gene expression within these cells. 
4. The large participation of detected modules of common signaling pathways, as well as their common putative control by 
transcription factors, retroactively brings credit to the hypothesis that expression co-variation is derived from functional 
linking (i.e. ‘the guilt-by-association’ principle).  
 Subjects: 59 children (Barnes et al., Arthritis Rheum. 2009 Jul;60(7):2102-12), 274 adults from 7 studies, 56 people from CD34+ study (Li 
et al., Cancer Cell. 2011 Nov 15;20(5):591-605), and 57 burn victims over two time points (early and late) (Xu et al., Proc Natl Acad Sci U S 
A. 2010 Jun 1;107(22):9923-8). 
 Microarray data files (GSMs) were downloaded from PubMed studies: Children: GSE13501(59); Adult: GSE21942 (15), GSE27034 (18), 
GSE14642 (20), GSE11761 (20), GSE46480 (98), GSE8507 (17), GSE10041 (23); CD34+: GSE23025 (56). Only controls were used. 
GSE19743 (63-controls, 57 early/late burn victims). 
Microarrays:  
 Microarrays were Affymetrix GeneChip® Human Genome U133 Plus 2.0 Arrays (GPL570) 
Data Processing Methods: 
 Single-Channel Array Normalization (SCAN) 
 Presence / Absence Scores using Affymetrix Expression Console 
 Pearson Correlation and Matrix analysis using Partek Discovery Suite 
 Weighted Gene Correlation Network Analysis (WGCNA) using the R program. 
 Clique Mining Network Detection 
Materials and Methods  
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Table 3: Most highly correlated ‘neighbors’ to CVR seed genes found by GBA in children:  Examples of candidate genes for 
repairome extension are listed here.  These genes have been found to be highly correlated with one of the original CVR genes and all have 
known roles in cardiovascular maintenance, repair, and/or cardiovascular diseases. 
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Figure 5: Signaling pathways of two gene clusters involved in response to burn injury, constructed with Ingenuity® Pathways 
analysis. (A) Pathways associated to „blue cluster‟ (obtained by direct targeted network representation, Fig. 3 B,C). (B) Pathways 
associated to „red cluster‟ obtained by GBA method. Of note, although the composition is different, both address similar functions and both 
are controlled by the transcription factor CCAAT/enhancer-binding protein alpha (CEBPA) (Rosmarin et al., Exp Hematol. 2005 
Feb;33(2):131-43) 
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